162 related articles for article (PubMed ID: 21147760)
1. Differences in CD75s- and iso-CD75s-ganglioside content and altered mRNA expression of sialyltransferases ST6GAL1 and ST3GAL6 in human hepatocellular carcinomas and nontumoral liver tissues.
Souady J; Hülsewig M; Distler U; Haier J; Denz A; Pilarsky C; Senninger N; Dreisewerd K; Peter-Katalinic J; Müthing J
Glycobiology; 2011 May; 21(5):584-94. PubMed ID: 21147760
[TBL] [Abstract][Full Text] [Related]
2. Tumor-associated CD75s- and iso-CD75s-gangliosides are potential targets for adjuvant therapy in pancreatic cancer.
Distler U; Souady J; Hülsewig M; Drmić-Hofman I; Haier J; Denz A; Grützmann R; Pilarsky C; Senninger N; Dreisewerd K; Berkenkamp S; Schmidt MA; Peter-Katalinic J; Müthing J
Mol Cancer Ther; 2008 Aug; 7(8):2464-75. PubMed ID: 18723492
[TBL] [Abstract][Full Text] [Related]
3. Tumor-associated CD75s gangliosides and CD75s-bearing glycoproteins with Neu5Acalpha2-6Galbeta1-4GlcNAc-residues are receptors for the anticancer drug rViscumin.
Müthing J; Meisen I; Kniep B; Haier J; Senninger N; Neumann U; Langer M; Witthohn K; Milosević J; Peter-Katalinić J
FASEB J; 2005 Jan; 19(1):103-5. PubMed ID: 15520251
[TBL] [Abstract][Full Text] [Related]
4. n-butyrate reduces the expression of beta-galactoside alpha 2,6-sialyltransferase in Hep G2 cells.
Shah S; Lance P; Smith TJ; Berenson CS; Cohen SA; Horvath PJ; Lau JT; Baumann H
J Biol Chem; 1992 May; 267(15):10652-8. PubMed ID: 1316908
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 facilitates cell migration by upregulating nuclear receptor 4A2/retinoid X receptor α-mediated β-galactoside α2,6-sialyltransferase I expression in human hepatocarcinoma cells.
Chen X; Wang L; Yu X; Wang S; Zhang J
Int J Biochem Cell Biol; 2021 Aug; 137():106027. PubMed ID: 34157397
[TBL] [Abstract][Full Text] [Related]
6. miR-9 inhibits the metastatic ability of hepatocellular carcinoma via targeting beta galactoside alpha-2,6-sialyltransferase 1.
Han Y; Liu Y; Fu X; Zhang Q; Huang H; Zhang C; Li W; Zhang J
J Physiol Biochem; 2018 Aug; 74(3):491-501. PubMed ID: 30006781
[TBL] [Abstract][Full Text] [Related]
7. Sialyltransferase ST3GAL6 mediates the effect of microRNA-26a on cell growth, migration, and invasion in hepatocellular carcinoma through the protein kinase B/mammalian target of rapamycin pathway.
Sun M; Zhao X; Liang L; Pan X; Lv H; Zhao Y
Cancer Sci; 2017 Feb; 108(2):267-276. PubMed ID: 27906498
[TBL] [Abstract][Full Text] [Related]
8. ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface.
Zou X; Lu J; Deng Y; Liu Q; Yan X; Cui Y; Xiao X; Fang M; Yang F; Sawaki H; Sato T; Tan B; Lu X; Feng B; Kuno A; Narimatsu H; Gao C; Zhang Y
Oncogene; 2023 Feb; 42(7):516-529. PubMed ID: 36528750
[TBL] [Abstract][Full Text] [Related]
9. Modification of sialylation mediates the invasive properties and chemosensitivity of human hepatocellular carcinoma.
Zhao Y; Li Y; Ma H; Dong W; Zhou H; Song X; Zhang J; Jia L
Mol Cell Proteomics; 2014 Feb; 13(2):520-36. PubMed ID: 24255131
[TBL] [Abstract][Full Text] [Related]
10. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
Merritt WD; Richardson CL; Keenan TW; Morré DJ
J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of ganglioside GD1a synthesis suppresses the differentiation of human mesenchymal stem cells into osteoblasts.
Yang HJ; Jung KY; Kwak DH; Lee SH; Ryu JS; Kim JS; Chang KT; Lee JW; Choo YK
Dev Growth Differ; 2011 Apr; 53(3):323-32. PubMed ID: 21492147
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of ST6Gal-I expression in human hepatocellular carcinoma cells inhibits their exosome-mediated proliferation- and migration-promoting effects.
Wang L; Chen X; Wang L; Wang S; Li W; Liu Y; Zhang J
IUBMB Life; 2021 Nov; 73(11):1378-1391. PubMed ID: 34559939
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical localization of ganglioside components in hepatocellular carcinoma and liver cirrhosis using monoclonal antibody.
Tanno M; Yamada H; Kyomasu Y; Inaniwa Y; Hano H; Myoga A
Lab Invest; 1993 Apr; 68(4):456-64. PubMed ID: 7683070
[TBL] [Abstract][Full Text] [Related]
14. Regulation of ST6GAL1 sialyltransferase expression in cancer cells.
Dorsett KA; Marciel MP; Hwang J; Ankenbauer KE; Bhalerao N; Bellis SL
Glycobiology; 2021 Jun; 31(5):530-539. PubMed ID: 33320246
[TBL] [Abstract][Full Text] [Related]
15. Thyroid sialyltransferase mRNA level and activity are increased in Graves' disease.
Kiljański J; Ambroziak M; Pachucki J; Jazdzewski K; Wiechno W; Stachlewska E; Górnicka B; Bogdańska M; Nauman J; Bartoszewicz Z
Thyroid; 2005 Jul; 15(7):645-52. PubMed ID: 16053379
[TBL] [Abstract][Full Text] [Related]
16. Characterization of P1 promoter activity of the beta-galactoside alpha2,6-sialyltransferase I gene (siat 1) in cervical and hepatic cancer cell lines.
Milflores-Flores L; Millán-Pérez L; Santos-López G; Reyes-Leyva J; Vallejo-Ruiz V
J Biosci; 2012 Jun; 37(2):259-67. PubMed ID: 22581331
[TBL] [Abstract][Full Text] [Related]
17. β-Galactoside α2,6-sialyltranferase 1 promotes transforming growth factor-β-mediated epithelial-mesenchymal transition.
Lu J; Isaji T; Im S; Fukuda T; Hashii N; Takakura D; Kawasaki N; Gu J
J Biol Chem; 2014 Dec; 289(50):34627-41. PubMed ID: 25344606
[TBL] [Abstract][Full Text] [Related]
18. Expression of Functional Human Sialyltransferases ST3Gal1 and ST6Gal1 in Escherichia coli.
Ortiz-Soto ME; Seibel J
PLoS One; 2016; 11(5):e0155410. PubMed ID: 27166796
[TBL] [Abstract][Full Text] [Related]
19. Structural analysis of brain ganglioside acetylation patterns in mice with altered ganglioside biosynthesis.
Mlinac K; Fabris D; Vukelić Z; Rožman M; Heffer M; Bognar SK
Carbohydr Res; 2013 Dec; 382():1-8. PubMed ID: 24140892
[TBL] [Abstract][Full Text] [Related]
20. Ganglioside variations in human liver cirrhosis and hepatocellular carcinoma as shown by two-dimensional thin-layer chromatography.
Tanno M; Yamada H; Shimada H; Ohashi M
Clin Biochem; 1988 Dec; 21(6):333-9. PubMed ID: 2853012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
